Tobam raised its stake in Molina Healthcare, Inc. (NYSE:MOH – Free Report) by 58.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,392 shares of the company’s stock after buying an additional 885 shares during the period. Tobam’s holdings in Molina Healthcare were worth $696,000 as of its most recent filing with the SEC.
Several other institutional investors also recently modified their holdings of the stock. Waldron Private Wealth LLC grew its holdings in shares of Molina Healthcare by 4.7% in the 4th quarter. Waldron Private Wealth LLC now owns 729 shares of the company’s stock worth $212,000 after acquiring an additional 33 shares during the last quarter. WCM Investment Management LLC boosted its position in shares of Molina Healthcare by 3.4% in the 3rd quarter. WCM Investment Management LLC now owns 1,080 shares of the company’s stock valued at $369,000 after purchasing an additional 36 shares during the period. Metis Global Partners LLC increased its stake in Molina Healthcare by 1.4% in the 3rd quarter. Metis Global Partners LLC now owns 2,785 shares of the company’s stock worth $960,000 after purchasing an additional 39 shares in the last quarter. Caprock Group LLC raised its holdings in Molina Healthcare by 3.3% during the 3rd quarter. Caprock Group LLC now owns 1,460 shares of the company’s stock worth $503,000 after buying an additional 47 shares during the period. Finally, Bank of Hawaii lifted its stake in Molina Healthcare by 4.6% during the third quarter. Bank of Hawaii now owns 1,224 shares of the company’s stock valued at $422,000 after buying an additional 54 shares in the last quarter. Institutional investors own 98.50% of the company’s stock.
Molina Healthcare Stock Down 10.0 %
MOH opened at $285.29 on Friday. The company has a market capitalization of $16.32 billion, a PE ratio of 14.49, a price-to-earnings-growth ratio of 0.96 and a beta of 0.54. The business has a 50-day moving average of $298.78 and a 200-day moving average of $318.38. Molina Healthcare, Inc. has a fifty-two week low of $272.69 and a fifty-two week high of $423.92. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.54 and a quick ratio of 1.55.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on the stock. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $350.00 target price (down from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Stephens reiterated an “equal weight” rating and set a $345.00 price objective on shares of Molina Healthcare in a research report on Thursday. Cantor Fitzgerald restated an “overweight” rating and issued a $406.00 target price on shares of Molina Healthcare in a report on Thursday, October 24th. StockNews.com upgraded Molina Healthcare from a “buy” rating to a “strong-buy” rating in a report on Friday, January 31st. Finally, Robert W. Baird reduced their price objective on Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, four have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $361.45.
View Our Latest Research Report on MOH
Molina Healthcare Company Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles
- Five stocks we like better than Molina Healthcare
- How to Invest in Biotech Stocks
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- The 3 Best Blue-Chip Stocks to Buy Now
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
- Investing in the High PE Growth Stocks
- These are the 3 Stocks Most Likely to Split in 2025
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.